Home › Breast Diseases
Breast Diseases clinical trials recruiting in the U.S.
8 studies for Breast Diseases are recruiting participants at sites across the United States.
Breast changes such as lumps, bumps, and discharge are common. Some causes can be aging, hormones, or medicines. Learn about symptoms and treatments.
Cities with the most studies
By state
- California6 studies
- Georgia3 studies
- Massachusetts3 studies
- Tennessee3 studies
- Texas7 studies
- Virginia4 studies
Recently updated studies
ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE) - iSono Health
RecruitingObservational study
Ages 18 to 94 · Women · Updated Sep 17, 2026 · NCT07505797A Study of Breast Cancer Risk Factors and Outcomes of People in Florida
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT06780176Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT05386108A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
RecruitingPhase 3
Ages 18 to 130 · All sexes · Updated Sep 8, 2026 · NCT07647328IMPACT: Improving Maternal Postpartum Access to Care Through Telemedicine
RecruitingHealthy volunteers welcome
Ages 18 and older · Women · Updated Sep 2, 2026 · NCT06218355First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 7, 2026 · NCT05768139Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jun 23, 2026 · NCT06993844Hormones, Outcomes, and Pain Pathways in Exercise Study
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 60 · Women · Updated Jun 2, 2026 · NCT07579182From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.